Literature DB >> 21723721

Structural insights into agonist-induced activation of G-protein-coupled receptors.

Xavier Deupi1, Jörg Standfuss.   

Abstract

Recent years have seen tremendous breakthroughs in structure determination of G-protein-coupled receptors (GPCRs). In 2011, two agonist-bound active-state structures of rhodopsin have been published. Together with structures of several rhodopsin activation intermediates and a wealth of biochemical and spectroscopic information, they provide a unique structural framework on which to understand GPCR activation. Here we use this framework to compare the recent crystal structures of the agonist-bound active states of the β(2) adrenergic receptor (β(2)AR) and the A(2A) adenosine receptor (A(2A)AR). While activation of these three GPCRs results in rearrangements of TM5 and TM6, the extent of this conformational change varies considerably. Displacements of the cytoplasmic side of TM6 ranges between 3 and 8Å depending on whether selective stabilizers of the active conformation are used (i.e. a G-protein peptide in the case of rhodopsin or a conformationally selective nanobody in the case of the β(2)AR) or not (A(2A)AR). The agonist-induced conformational changes in the ligand-binding pocket are largely receptor specific due to the different chemical nature of the agonists. However, several similarities can be observed, including a relocation of conserved residues W6.48 and F6.44 towards L5.51 and P5.50, and of I/L3.40 away from P5.50. This transmission switch links agonist binding to the movement of TM5 and TM6 through the rearrangement of the TM3-TM5-TM6 interface, and possibly constitutes a common theme of GPCR activation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723721     DOI: 10.1016/j.sbi.2011.06.002

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  89 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

2.  Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.

Authors:  Maarten L J Doornbos; Laura Pérez-Benito; Gary Tresadern; Thea Mulder-Krieger; Ilse Biesmans; Andrés A Trabanco; Jose María Cid; Hilde Lavreysen; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2016-01-13       Impact factor: 8.739

3.  Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor.

Authors:  Sophie Mary; Marjorie Damian; Maxime Louet; Nicolas Floquet; Jean-Alain Fehrentz; Jacky Marie; Jean Martinez; Jean-Louis Banères
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-09       Impact factor: 11.205

4.  Identification of avian vasotocin receptor subtype-specific antagonists involved in the stress response of the chicken, Gallus gallus.

Authors:  Seong W Kang; Srinivas Jayanthi; Gurueswar Nagarajan; Thallapuranam Krishnaswamy Suresh Kumar; Wayne J Kuenzel
Journal:  J Biomol Struct Dyn       Date:  2018-05-17

5.  Lipids Alter Rhodopsin Function via Ligand-like and Solvent-like Interactions.

Authors:  Leslie A Salas-Estrada; Nicholas Leioatts; Tod D Romo; Alan Grossfield
Journal:  Biophys J       Date:  2018-01-23       Impact factor: 4.033

6.  Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor.

Authors:  Yinglong Miao; Alisha D Caliman; J Andrew McCammon
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

Review 7.  Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.

Authors:  Kristen A Marino; Yi Shang; Marta Filizola
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

8.  Intracellular allosteric antagonism of the CCR9 receptor.

Authors:  Christine Oswald; Mathieu Rappas; James Kean; Andrew S Doré; James C Errey; Kirstie Bennett; Francesca Deflorian; John A Christopher; Ali Jazayeri; Jonathan S Mason; Miles Congreve; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

9.  Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Authors:  Ali Jazayeri; Mathieu Rappas; Alastair J H Brown; James Kean; James C Errey; Nathan J Robertson; Cédric Fiez-Vandal; Stephen P Andrews; Miles Congreve; Andrea Bortolato; Jonathan S Mason; Asma H Baig; Iryna Teobald; Andrew S Doré; Malcolm Weir; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

Review 10.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.